Impact of Age and Gender on Survival of Glioblastoma Multiforme Patients: A Multicenter Retrospective Study.

IF 1.5 Q4 ONCOLOGY Cancer reports Pub Date : 2024-11-01 DOI:10.1002/cnr2.70050
Zoheir Reihanian, Elahe Abbaspour, Nooshin Zaresharifi, Sahand Karimzadhagh, Maral Mahmoudalinejad, Ainaz Sourati, Mohaya Farzin, Habib EslamiKenarsari
{"title":"Impact of Age and Gender on Survival of Glioblastoma Multiforme Patients: A Multicenter Retrospective Study.","authors":"Zoheir Reihanian, Elahe Abbaspour, Nooshin Zaresharifi, Sahand Karimzadhagh, Maral Mahmoudalinejad, Ainaz Sourati, Mohaya Farzin, Habib EslamiKenarsari","doi":"10.1002/cnr2.70050","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Glioblastoma multiforme (GBM) poses a significant health challenge as the most common primary malignancy of the adult central nervous system. Gender- and age-related differences in GBM influence prognosis and treatment complexities. This multicenter retrospective study explores gender and age disparities in GBM patients, investigating their impact on occurrence and survival outcomes.</p><p><strong>Methods: </strong>This multicenter retrospective study involved GBM patients treated in Guilan Province, Iran. Patients' data, including age, gender, tumor location, and histopathological diagnosis date, was collected from medical records.</p><p><strong>Results: </strong>In a cohort of 164 GBM patients, the average age was 54.34 ± 14.16 years, with a higher prevalence among men (59.8%) and patients aged ≤ 60 years (64.6%). The tumor sites exhibited overlapping features in 68% of cases, with the frontal and temporal lobes being the most common specific locations. The mean survival was 12.88 ± 14.14 months, one-year survival of 45%, with women showing significantly higher one-year survival (60% vs. 40%) and longer mean survival (16.14 ± 17.35 vs. 10.75 ± 11.15 months). Furthermore, Patients ≤ 60 years had significantly higher one-year survival (75% vs. 35%). In subgroup analysis, women had significantly higher survival rates in patients ≤ 60 years. However, among patients over 60, women exhibited a more pronounced decline in survival rates, with no statistically significant difference between men and women in this age group.</p><p><strong>Conclusion: </strong>This study highlights that both age and gender significantly affect GBM survival outcomes. Younger patients, particularly women, exhibited better survival rates, while older patients, especially women, showed poorer outcomes. These findings suggest the need to stratify treatment approaches by both age and gender to optimize care and improve survival in GBM patients. Further research is recommended to explore these associations.</p>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541054/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/cnr2.70050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Glioblastoma multiforme (GBM) poses a significant health challenge as the most common primary malignancy of the adult central nervous system. Gender- and age-related differences in GBM influence prognosis and treatment complexities. This multicenter retrospective study explores gender and age disparities in GBM patients, investigating their impact on occurrence and survival outcomes.

Methods: This multicenter retrospective study involved GBM patients treated in Guilan Province, Iran. Patients' data, including age, gender, tumor location, and histopathological diagnosis date, was collected from medical records.

Results: In a cohort of 164 GBM patients, the average age was 54.34 ± 14.16 years, with a higher prevalence among men (59.8%) and patients aged ≤ 60 years (64.6%). The tumor sites exhibited overlapping features in 68% of cases, with the frontal and temporal lobes being the most common specific locations. The mean survival was 12.88 ± 14.14 months, one-year survival of 45%, with women showing significantly higher one-year survival (60% vs. 40%) and longer mean survival (16.14 ± 17.35 vs. 10.75 ± 11.15 months). Furthermore, Patients ≤ 60 years had significantly higher one-year survival (75% vs. 35%). In subgroup analysis, women had significantly higher survival rates in patients ≤ 60 years. However, among patients over 60, women exhibited a more pronounced decline in survival rates, with no statistically significant difference between men and women in this age group.

Conclusion: This study highlights that both age and gender significantly affect GBM survival outcomes. Younger patients, particularly women, exhibited better survival rates, while older patients, especially women, showed poorer outcomes. These findings suggest the need to stratify treatment approaches by both age and gender to optimize care and improve survival in GBM patients. Further research is recommended to explore these associations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
年龄和性别对多形性胶质母细胞瘤患者存活率的影响:一项多中心回顾性研究
背景:多形性胶质母细胞瘤(GBM多形性胶质母细胞瘤(GBM)是成人中枢神经系统最常见的原发性恶性肿瘤,对健康构成重大挑战。GBM 的性别和年龄差异影响着预后和治疗的复杂性。这项多中心回顾性研究探讨了 GBM 患者的性别和年龄差异,研究其对发生和生存结果的影响:这项多中心回顾性研究涉及在伊朗吉兰省接受治疗的 GBM 患者。从病历中收集患者数据,包括年龄、性别、肿瘤位置和组织病理学诊断日期:在 164 例 GBM 患者中,平均年龄为(54.34 ± 14.16)岁,男性(59.8%)和年龄小于 60 岁的患者(64.6%)发病率较高。68%的病例的肿瘤部位具有重叠特征,额叶和颞叶是最常见的特定部位。平均生存期为(12.88 ± 14.14)个月,一年生存率为 45%,其中女性的一年生存率(60% vs. 40%)和平均生存期(16.14 ± 17.35 vs. 10.75 ± 11.15)明显更高。此外,60 岁以下患者的一年生存率明显更高(75% 对 35%)。在亚组分析中,女性患者的生存率明显高于≤60岁的患者。然而,在60岁以上的患者中,女性的存活率下降更为明显,该年龄组中男女之间的差异在统计学上并不显著:结论:本研究强调,年龄和性别对 GBM 的存活率有重大影响。年轻患者,尤其是女性患者的生存率较高,而年长患者,尤其是女性患者的生存率较低。这些发现表明,有必要根据年龄和性别对治疗方法进行分层,以优化治疗并提高 GBM 患者的生存率。建议进一步开展研究,探讨这些关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
期刊最新文献
Analysis of Wilms Tumour Epidemiology, Clinicopathological Features and Treatment Outcomes in 84 Moroccan Patients. Definite Treatment Delay With Neoadjuvant Chemotherapy and Longitudinal Monitoring by Circulating Tumor DNA for Advanced Cervical Cancer During Pregnancy: A Case Series and Literature Review. Impact of Age and Gender on Survival of Glioblastoma Multiforme Patients: A Multicenter Retrospective Study. Significant Pathologic Response Following Neoadjuvant Therapy and Curative Resection in Patients With Rectal Cancer: Surgical and Oncological Outcomes From a Retrospective Cohort Study. Total Minimally Invasive Curative Staged Resections After Induction Systemic Therapy for Metastatic Rectal Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1